Sponsors (4)
Introduced May 1, 2025 by Christopher A. Coons · Last progress May 1, 2025
The bill strengthens protections, procedures, and funding flexibility for patent owners and the USPTO—boosting certainty for rights‑holders and some researchers—at the cost of making post‑grant challenges harder, potentially preserving weak patents, increasing costs for competitors and consumers, and reducing some external oversight and transparency.
Patent owners (inventors, small businesses, universities) gain stronger legal protection for issued patents because the bill aligns PTAB standards with district-court burdens and preserves presumption of validity, making commercialization and investment more secure.
Patent holders and applicants get faster, clearer agency timelines and more predictable PTAB procedures (set rehearing deadlines, clearer claim‑amendment processes, and limits on repetitive petitions), reducing prolonged uncertainty about patent validity.
Increased transparency about who funds patent challenges (real‑party‑in‑interest disclosures) and new PTAB conduct/recusal rules aim to make post‑grant proceedings more open and reduce improper influence.
Small businesses, competitors, and consumers face higher barriers to invalidating weak patents because the bill raises burdens (clear‑and‑convincing standards, heightened petition certifications, broader estoppel, and single‑forum limits), making it harder and costlier to challenge bad patents.
Preserving or making it harder to remove weak or overly broad patents risks higher prices, reduced competition, and greater litigation costs for downstream businesses and consumers.
PTAB procedural changes (mandatory three‑member panels, stricter recusal, new ethics/recording rules) and added administrative requirements could slow adjudications, raise costs for all parties, and reduce hearing capacity.
Based on analysis of 9 sections of legislative text.
Changes patent-review procedures at the U.S. Patent and Trademark Office to tighten who can bring and fund inter partes reviews, post‑grant reviews, and ex parte reexaminations; increases procedural limits, deadlines, and evidentiary standards that favor patent owners; requires PTAB panels of at least three members, new ethics/recusal rules, and greater Director review authority; ends fee diversion by creating a USPTO revolving Innovation Promotion Fund paid from patent and trademark fees; expands who may claim micro‑entity status for reduced fees; and directs the SBA to report on small business patent ownership and litigation while requiring free public online access to PTO public-search resources where feasible. These changes change filing, discovery, joinder, estoppel, and claim‑construction rules and set specific timing requirements for rehearings and remand decisions.